Biochemical and genetic risk factors for atherosclerosis in systemic lupus erythematosus

Egyptian Rheumatologist - Tập 33 - Trang 35-43 - 2011
Hanan El Saadany1, Mervat El-Sergany1, Elham Kasem1, Manal M. El-Batch2, Soha S. Zakaria2, Heba Mourad3, Timour Moustafa4
1Physical Medicine, Rheumatology & Rehabilitation Department, Faculty of Medicine, Tanta University, Egypt
2Medical Biochemistry Department, Faculty of Medicine, Tanta University, Egypt
3Clinical Pathology Department, Faculty of Medicine, Tanta University, Egypt
4Cardiology Department, Faculty of Medicine, Tanta University, Egypt

Tài liệu tham khảo

Kariuki, 2010, Genetic regulation of serum cytokines in systemic lupus erythematosus, Translat Res, 155, 109, 10.1016/j.trsl.2009.08.012

Ghosh, 2009, Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus, Clin Rheumatol, 28, 1259, 10.1007/s10067-009-1228-6

Koca, 2009, Insulin resistance is related with oxidative stress in systemic lupus erythematosus, Anadolu Kardiyol Derg, 9, 23

Haque, 2008, Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus, Curr Opin Lipidol, 19, 338, 10.1097/MOL.0b013e328304b65f

Colombo, 2007, Intima–media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus, Ann NY Acad Sci, 1108, 121, 10.1196/annals.1422.014

Blackwell, 2010, The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine, Ann Clin Biochem, 47, 17, 10.1258/acb.2009.009196

Landim, 2009, Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis, Clinics, 64, 471, 10.1590/S1807-59322009000500015

Yuasa, 2009, MCP-1 gene A−2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes, Diabetes Res Clin Pract, 86, 193, 10.1016/j.diabres.2009.09.001

Rua Figueroa, 2010, Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study, Ann Rheum Dis, 69, 1136, 10.1136/ard.2008.104349

Corrado, 2010, An update on the role of markers of inflammation in atherosclerosis, J Atheroscler Theromb, 17, 1, 10.5551/jat.2600

Aguilar, 2001, MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus, Tissue Antigens, 58, 335, 10.1034/j.1399-0039.2001.580508.x

Ito, 2003, Inflammatory cytokines and cardiovascular disease, Curr Drug Targets Inflamm Allergy, 2, 257, 10.2174/1568010033484106

Montecucco, 2009, Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis, Rheumatology (Oxford), 48, 11, 10.1093/rheumatology/ken395

Nyquist, 2009, Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis, Cerebrovasc Dis, 28, 124, 10.1159/000223437

Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928

Bombardier, 1992, Derivation of the SLEDAI: a disease activity index for lupus patients, Arthritis Rheum, 35, 630, 10.1002/art.1780350606

Sidhu, 1997, A simple and reproducible method for assessing intimal–medial thickness of the common carotid artery, Brit J Radiol, 70, 85, 10.1259/bjr.70.829.9059301

Lu, 2003, Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention, Eur Heart J, 24, 1912, 10.1016/j.ehj.2003.08.013

Auer, 2002, C-reactive protein and coronary artery disease, Jpn Heart J, 43, 607, 10.1536/jhj.43.607

Leonard, 1990, Human monocyte chemoattractant protein-1 (MCP-1), Immunol Today, 11, 97, 10.1016/0167-5699(90)90035-8

Rovin, 1999, A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression, Biochem Biophys Res Commun, 259, 344, 10.1006/bbrc.1999.0796

Manzi, 2009, Atherosclerosis risk factors in systemic lupus erythematosus, Curr Rheumatol Rep, 11, 241, 10.1007/s11926-009-0034-0

Cacciapaglia, 2009, Stiffness parameters, intima–media thickness and early atherosclerosis in systemic lupus erythematosus patients, Lupus, 18, 249, 10.1177/0961203308097571

Sato, 2007, Atherosclerosis is accelerated in patients with long-term well-controlled systemic lupus erythematosus (SLE), Clin Chim Acta, 385, 35, 10.1016/j.cca.2007.04.023

El Magadmi, 2004, Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women, Circulation, 110, 399, 10.1161/01.CIR.0000136807.78534.50

Carotti, 2007, Reumatismo, 59, 38

Del Sol, 2001, Is carotid intima–media thickness useful in cardiovascular disease risk assessment? The Rotterdam study, Stroke, 32, 1532, 10.1161/01.STR.32.7.1532

McMahon, 2007, Atherosclerosis and systemic lupus erythematosus – mechanistic basis of the association, Curr Opin Immunol, 19, 633, 10.1016/j.coi.2007.11.001

Valdivielso, 2008, Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis, Clin Exp Rheumatol, 26, 827

Bultink, 2005, Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity and organ damage in patients with systemic lupus erythematosus, Ann Rheum Dis, 64, 1362, 10.1136/ard.2005.036137

Sydow, 2003, ADMA and oxidative stress, Atheroscler Suppl, 4, 41, 10.1016/S1567-5688(03)00033-3

Boger, 2000, An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes, J Am Coll Cardiol, 36, 2287, 10.1016/S0735-1097(00)01013-5

Abou Raya, 2006, Inflammation: a pivotal link between autoimmune diseases and atherosclerosis, Autoimmun Rev, 5, 331, 10.1016/j.autrev.2005.12.006

Barnes, 2005, High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk, Lupus, 14, 576, 10.1191/0961203305lu2157oa

Roh, 2007, A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein, J Korean Med Sci, 22, 192, 10.3346/jkms.2007.22.2.192

Olsen, 2006, High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors, J Hypertens, 24, 655, 10.1097/01.hjh.0000217847.03208.ba

Aiello, 1999, Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice, Arterioscler Thromb Vasc Biol, 19, 1518, 10.1161/01.ATV.19.6.1518

Reckless, 1999, Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions, Circulation, 99, 2310, 10.1161/01.CIR.99.17.2310

Brown, 2007, Monocyte chemoattractant protein-1: plasma concentrations and A(−2518)G promoter polymorphism of its gene in systemic lupus erythematosus, J Rheumatol, 34, 740

Deo, 2004, Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors and subclinical atherosclerosis, J Am Coll Cardiol, 44, 1812, 10.1016/j.jacc.2004.07.047

Gustafson, 2010, Adipose tissue, inflammation and atherosclerosis, J Atheroscler Thromb, 17, 332, 10.5551/jat.3939

Schepers, 2006, Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo, Arterioscler Thromb Vasc Biol, 26, 2063, 10.1161/01.ATV.0000235694.69719.e2

Szalai, 2001, Involvement of polymorphisms in the chemokine system in the susceptibility for Coronary Artery Disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients, Atherosclerosis, 158, 233, 10.1016/S0021-9150(01)00423-3

Tucci, 2004, Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis, Arthritis Rheum, 50, 1842, 10.1002/art.20266

Sánchez, 2006, Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus, BMC Med Genet, 7, 48, 10.1186/1471-2350-7-48

Tabara, 2003, Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima–media thickness, Hypertens Res, 26, 677, 10.1291/hypres.26.677

Buraczynska, 2008, Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients, Cytokine, 44, 361, 10.1016/j.cyto.2008.10.001

Lima, 2007, MCP-1, RANTES and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus, Human Immunol, 68, 980, 10.1016/j.humimm.2007.10.007

Furuki, 2008, Plasma level of asymmetric dimethylarginine (ADMA) as a predictor of carotid intima–media thickness progression: six-year prospective study using carotid ultrasonography, Hypertens Res, 31, 1185, 10.1291/hypres.31.1185

Thông tin
Thông tin xuất bản

Egyptian Rheumatologist

Tập 33

35-43

Thông tin tác giả